Zulekha Hospital Dubai is a trusted healthcare provider for Papillary Thyroid Cancer Treatment, offering multidisciplinary thyroid cancer care supported by experienced specialists and modern medical infrastructure. Established in 2004, the JCI hospital is situated in Dubai, United Arab Emirates and has 179 beds.

Papillary Thyroid Cancer is the most common type of thyroid cancer and generally develops from thyroid follicular cells. Treatment is selected according to factors such as tumor size, spread, lymph node involvement, and recurrence risk. Depending on the patient's condition, treatment may include surgery, radioactive iodine therapy, thyroid hormone therapy, targeted therapy, or active surveillance for selected low-risk tumors. Comprehensive evaluation and regular follow-up help monitor treatment response and thyroid health.